Home › Funds › DODGE & COX › GSK

DODGE & COX position in GSK

GSK PLC · Health Care

DODGE & COX reported holding 43,183,117 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$2.08B, representing 1.12% of its reported portfolio and ranking #33 among its reported holdings. DODGE & COX has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)43.18M sh
Reported value held$2.08B
Portfolio Weight1.12%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How DODGE & COX's GSK position evolved

DODGE & COX first disclosed a stake in GSK in Q3 2023 at 69,281,183 shares (US$2.51B). The position peaked in Q3 2025 at 78,403,734 shares, worth US$3.38B. Across 13 filings, DODGE & COX increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 43,183,117 shares valued at US$2.08B — a reduction of -5,014,397 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 69.28M $2.51B New
Q4 2023 69.03M $2.56B Hold
Q1 2024 68.86M $2.95B Hold
Q2 2024 68.34M $2.63B Reduce
Q3 2024 68.09M $2.78B Hold
Q4 2024 68.44M $2.31B Add
Q1 2025 78.65M $3.05B Add
Q2 2025 78.76M $3.02B Hold
Q3 2025 78.40M $3.38B Hold
Q4 2025 68.52M $3.36B Reduce
Q1 2026 58.66M $3.24B Reduce
Q2 2026 48.20M $2.53B Reduce
Q3 2026 43.18M $2.08B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 19 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B), JTC Employer Solutions Trustee Ltd (US$389.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has DODGE & COX held GSK?

DODGE & COX has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DODGE & COX's current position in GSK?

As of Q3 2026, DODGE & COX holds 43.18M shares of GSK (GSK PLC), valued at $2.08B, representing 1.12% of its reported portfolio and ranking #33.

Has DODGE & COX been buying or selling GSK?

In the latest 13F filing (Q3 2026), DODGE & COX reduced its position in GSK. The position peaked in Q3 2025 at 78.40M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, JTC Employer Solutions Trustee Ltd, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.